Evidence map›Paper›PMID 30262816›Full record

ArticleNature genetics2018

Dynamic 3D chromatin architecture contributes to enhancer specificity and limb morphogenesis.

Bjørt K Kragesteen, Malte Spielmann, Christina Paliou, Verena Heinrich, Robert Schöpflin, Andrea Esposito, Carlo Annunziatella, Simona Bianco, Andrea M Chiariello, Ivana Jerković and 14 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 210 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Polymorphic 3D genome architecture mediated by transposable elements.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 3 countries.

Bjørt K KragesteenRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-9999-2067
Malte SpielmannRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-0583-4683
Christina PaliouRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0003-3383-2527
Verena HeinrichDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Robert SchöpflinRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Andrea EspositoDipartimento di Fisica, Università di Napoli Federico II, and Istituto Nazionale di Fisica Nucleare, Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.ORCID http://orcid.org/0000-0002-5903-8439
Carlo AnnunziatellaDipartimento di Fisica, Università di Napoli Federico II, and Istituto Nazionale di Fisica Nucleare, Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.
Simona BiancoDipartimento di Fisica, Università di Napoli Federico II, and Istituto Nazionale di Fisica Nucleare, Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.ORCID http://orcid.org/0000-0001-5819-060X
Andrea M ChiarielloDipartimento di Fisica, Università di Napoli Federico II, and Istituto Nazionale di Fisica Nucleare, Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.
Ivana JerkovićRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0001-9707-8303
Izabela HarabulaRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Philine GuckelbergerRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-1057-2518
Michael PechsteinRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Lars WittlerDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Wing-Lee ChanInstitute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Martin FrankeRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-4626-3290
Darío G LupiáñezRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-3165-036X
Katerina KraftRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-2011-6946
Bernd TimmermannMax Planck Institute for Molecular Genetics, Sequencing Core Facility, Berlin, Germany.
Martin VingronDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-1765-4241
Axel ViselLawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-4130-7784
Mario NicodemiDipartimento di Fisica, Università di Napoli Federico II, and Istituto Nazionale di Fisica Nucleare, Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy. nicodem@na.infn.it.ORCID http://orcid.org/0000-0002-8416-6416
Stefan MundlosRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany. mundlos@molgen.mpg.de.ORCID http://orcid.org/0000-0002-9788-3166
Guillaume AndreyRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany. andrey@molgen.mpg.de.ORCID http://orcid.org/0000-0002-0911-4907
Max Planck Institute for Molecular Genetics · DEIstituto Nazionale di Fisica Nucleare · ITBerlin-Brandenburger Centrum für Regenerative Therapien · DECharité - Universitätsmedizin Berlin · DELawrence Berkeley National Laboratory · USMax Delbrück Center · DE

Funding

Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Center for Mammalian Regulatory GenomicsU54HG006997 · NHGRI · LUDWIG INSTITUTE FOR CANCER RES LTD · PI REN, BING · 2012 to 2016
$14.3M
San Diego Center for 4D Nucleome ResearchU54DK107977 · NIDDK · LUDWIG INSTITUTE FOR CANCER RES LTD · PI REN, BING · 2015 to 2019
$9.4M
Regulation of Cardiac Development in Health and DiseaseUM1HL098166 · NHLBI · HARVARD MEDICAL SCHOOL · PI PENNACCHIO, LEN ALEXANDER, PU, WILLIAM TSWENCHING · 2015 to 2019
$4.4M
Genome-Wide Resources for Transcriptional Enhancers Active in the Human HeartR24HL123879 · NHLBI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PENNACCHIO, LEN ALEXANDER, VISEL, AXEL · 2015 to 2019
$3.9M
NHGRI NIH HHS R01 HG003988NHGRI NIH HHS U54 HG006997NHLBI NIH HHS R24 HL123879NHLBI NIH HHS UM1 HL098166NIDDK NIH HHS U54 DK107977
6 · The paper itself

Abstract

The regulatory specificity of enhancers and their interaction with gene promoters is thought to be controlled by their sequence and the binding of transcription factors. By studying Pitx1, a regulator of hindlimb development, we show that dynamic changes in chromatin conformation can restrict the activity of enhancers. Inconsistent with its hindlimb-restricted expression, Pitx1 is controlled by an enhancer (Pen) that shows activity in forelimbs and hindlimbs. By Capture Hi-C and three-dimensional modeling of the locus, we demonstrate that forelimbs and hindlimbs have fundamentally different chromatin configurations, whereby Pen and Pitx1 interact in hindlimbs and are physically separated in forelimbs. Structural variants can convert the inactive into the active conformation, thereby inducing Pitx1 misexpression in forelimbs, causing partial arm-to-leg transformation in mice and humans. Thus, tissue-specific three-dimensional chromatin conformation can contribute to enhancer activity and specificity in vivo and its disturbance can result in gene misexpression and disease.

Indexed as

Molecular ConformationAnimalsChromatinChromatin Assembly and DisassemblyCRISPR-Cas SystemsDNAEmbryo, MammalianEnhancer Elements, GeneticForelimbGene Expression Regulation, DevelopmentalHindlimbMiceMice, TransgenicMorphogenesisNucleic Acid ConformationPaired Box Transcription FactorsChromatinDNAhomeobox protein PITX1Paired Box Transcription Factors

Identifiers

PMID30262816
PMCPMC10154999
OpenAlexW2890753820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.